Accelerated decline in renal function after acute myocardial infarction in patients with high low-density lipoprotein-cholesterol to high-density lipoprotein-cholesterol ratio

被引:0
作者
Satoshi Okumura
Masaki Sakakibara
Ryo Hayashida
Yasushi Jinno
Akihito Tanaka
Koji Okada
Mutsuharu Hayashi
Hideki Ishii
Toyoaki Murohara
机构
[1] Nagoya University Graduate School of Medicine,Department of Cardiology
[2] Handa City Hospital,Department of Cardiology
来源
Heart and Vessels | 2014年 / 29卷
关键词
Renal function; Acute myocardial infarction; Low-density lipoprotein-cholesterol to high-density lipoprotein-cholesterol ratio; Lipids; Statin;
D O I
暂无
中图分类号
学科分类号
摘要
High low-density lipoprotein-cholesterol to high-density lipoprotein-cholesterol (L/H) ratio is associated with progressions of coronary arteriosclerosis and chronic kidney disease. On the other hand, renal function markedly declined after acute myocardial infarction (AMI). The aims of the present study were (1) to identify what type of patients with AMI would have high L/H ratio at follow-up and (2) to evaluate whether decline in renal function after AMI had accelerated or not in patients with high L/H ratio. The 190 eligible AMI patients who underwent primary percutaneous coronary intervention (PCI) and received atorvastatin (10 mg) were divided into one of two groups according to the L/H ratio at 6-month follow-up: L/H >2 group (n = 81) or L/H ≤2 group (n = 109). The characteristics on admission in the two groups were examined. Furthermore, changes in serum creatinine (sCr) and estimated glomerular filtration rate (eGFR) during 1- and 6-month follow-up were compared between the two groups. L/H >2 group were significantly younger and had greater body mass index (BMI) and worse lipid profile on admission compared with L/H ≤2 group. Percentage increase in sCr and percentage decrease in eGFR during 1-month follow-up in L/H >2 group tended to be greater than in L/H ≤2 group, and those during 6-month follow-up were significantly greater (16.5 ± 2.77 vs. 9.79 ± 2.23 %, p = 0.03 and 11.8 ± 1.93 vs. 2.75 ± 3.85 %, p = 0.04, respectively). In AMI patients undergoing primary PCI, those who were young and had large BMI and poor lipid profile on admission were likely to have a high L/H ratio at follow-up despite statin therapy. In addition, the decline in renal function after AMI had significantly accelerated in patients with high L/H ratio.
引用
收藏
页码:7 / 14
页数:7
相关论文
共 252 条
[1]  
Nicholls SJ(2007)Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis JAMA 297 499-508
[2]  
Tuzcu EM(2011)Impact of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio on long-term outcome in patients undergoing percutaneous coronary intervention Circ J 75 905-910
[3]  
Sipahi I(1993)Cholesterol: a renal risk factor in diabetic nephropathy? Am J Kidney Dis 22 196-201
[4]  
Grasso AW(1998)Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia Arch Intern Med 158 998-1004
[5]  
Schoenhagen P(1997)Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency Nephrol Dial Transplant 12 1908-1915
[6]  
Hu T(2005)Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study Kidney Int 58 293-301
[7]  
Wolski K(1995)Effects of hypertension and dyslipidemia on the decline in renal function Hypertension 26 670-675
[8]  
Crowe T(2003)Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial Eur Heart J 24 412-420
[9]  
Desai MY(2001)Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial JAMA 285 1711-1718
[10]  
Hazen SL(2004)Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 1495-1504